1. Home
  2. MFI vs MBIO Comparison

MFI vs MBIO Comparison

Compare MFI & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MFI
  • MBIO
  • Stock Information
  • Founded
  • MFI 2002
  • MBIO 2015
  • Country
  • MFI Hong Kong
  • MBIO United States
  • Employees
  • MFI N/A
  • MBIO 80
  • Industry
  • MFI
  • MBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • MFI
  • MBIO Health Care
  • Exchange
  • MFI NYSE
  • MBIO Nasdaq
  • Market Cap
  • MFI 8.6M
  • MBIO 7.3M
  • IPO Year
  • MFI 2024
  • MBIO N/A
  • Fundamental
  • Price
  • MFI $0.73
  • MBIO $5.55
  • Analyst Decision
  • MFI
  • MBIO Strong Buy
  • Analyst Count
  • MFI 0
  • MBIO 1
  • Target Price
  • MFI N/A
  • MBIO $2.00
  • AVG Volume (30 Days)
  • MFI 4.4M
  • MBIO 468.6K
  • Earning Date
  • MFI 02-15-2025
  • MBIO 03-10-2025
  • Dividend Yield
  • MFI N/A
  • MBIO N/A
  • EPS Growth
  • MFI N/A
  • MBIO N/A
  • EPS
  • MFI N/A
  • MBIO N/A
  • Revenue
  • MFI $3,877,747.00
  • MBIO N/A
  • Revenue This Year
  • MFI N/A
  • MBIO N/A
  • Revenue Next Year
  • MFI N/A
  • MBIO N/A
  • P/E Ratio
  • MFI N/A
  • MBIO N/A
  • Revenue Growth
  • MFI N/A
  • MBIO N/A
  • 52 Week Low
  • MFI $0.51
  • MBIO $5.19
  • 52 Week High
  • MFI $14.49
  • MBIO $76.00
  • Technical
  • Relative Strength Index (RSI)
  • MFI N/A
  • MBIO 31.43
  • Support Level
  • MFI N/A
  • MBIO $5.19
  • Resistance Level
  • MFI N/A
  • MBIO $13.30
  • Average True Range (ATR)
  • MFI 0.00
  • MBIO 2.31
  • MACD
  • MFI 0.00
  • MBIO -0.47
  • Stochastic Oscillator
  • MFI 0.00
  • MBIO 2.14

About MFI MF INTERNATIONAL LIMITED

mF International Ltd is a holding company and all of its operations are carried out by Operating Subsidiaries in Hong Kong. It is a financial trading solution provider principally engaged in the development and provision of financial trading solutions. It has experience in providing real-time mission-critical forex, bullion/commodities trading platform solutions, financial value-added services, mobile applications, and financial information for brokers and institutional clients via internet or platform as software as a service. The company has provided a wide range of top-notch services, including mF4 Trading Platform, Bridge and Plugins, CRM System, ECN System, Liquidity Solutions, Cross-platform Broker Plus Solution, Social Trading Applications and others.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: